Nyxoah Investor Relations Material
Latest events
Q4 2024
Nyxoah
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nyxoah S.A.
Access all reports
Nyxoah S.A. is a medical technology company that specializes in developing and commercializing innovative treatments for Obstructive Sleep Apnea (OSA). The company's flagship product, the Genio system, offers a patient-centric and CE-Marked hypoglossal neurostimulation therapy designed to treat moderate to severe cases of OSA. This therapy serves as an alternative for patients who are unable or unwilling to tolerate Continuous Positive Airway Pressure (CPAP) treatments. The company is headquartered in Mont-Saint-Guibert, Belgium, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
NYXH
Country
🇺🇸 United States